Trial Profile
Phase I trial of Vaxart's oral ebola virus vaccine
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 13 Jan 2015
Price :
$35
*
At a glance
- Drugs Ebola virus vaccine (Primary)
- Indications Ebola virus infections
- Focus Adverse reactions
- Sponsors Vaxart
- 13 Jan 2015 New trial record
- 08 Jan 2015 This trial of Vaxart's Ebola tablet vaccine is expected be initiated in the first quarter of 2015, according to a company media release.